AU3597600A - High numerical aperture flow cytometer and method of using same - Google Patents
High numerical aperture flow cytometer and method of using same Download PDFInfo
- Publication number
- AU3597600A AU3597600A AU35976/00A AU3597600A AU3597600A AU 3597600 A AU3597600 A AU 3597600A AU 35976/00 A AU35976/00 A AU 35976/00A AU 3597600 A AU3597600 A AU 3597600A AU 3597600 A AU3597600 A AU 3597600A
- Authority
- AU
- Australia
- Prior art keywords
- light
- scattered
- light detector
- flow cytometer
- laser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 20
- 210000004027 cell Anatomy 0.000 claims description 43
- 210000003979 eosinophil Anatomy 0.000 claims description 32
- 239000002245 particle Substances 0.000 claims description 18
- 210000000601 blood cell Anatomy 0.000 claims description 16
- 239000012530 fluid Substances 0.000 claims description 11
- 210000000265 leukocyte Anatomy 0.000 claims description 10
- 241000700605 Viruses Species 0.000 claims description 2
- 239000010453 quartz Substances 0.000 claims description 2
- 239000004065 semiconductor Substances 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 230000010287 polarization Effects 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 241000282465 Canis Species 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000002934 lysing effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/016—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1434—Optical arrangements
- G01N2015/1447—Spatial selection
Landscapes
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
WO 00/49387 PCT/USOO/04069 HIGH NUMERICAL APERTURE FLOW CYTOMETER AND METHOD OF USING SAME FIELD OF THE INVENTION The present invention relates to particle discrimination by light scattering, and more particularly to a flow cytometer and method therefore that discriminates particles employing a high numerical aperture. Numerical aperture is defined as the refractive index of the medium through which light is collected multiplied by the sine value of one half of the angle of light collection. BACKGROUND OF THE INVENTION The discrimination of particles is useful in numerous clinical assays including ascertaining the types and numerical quantity of cells in blood, ascertaining invasive particles in a fluid sample, such as bacteria and virus, and quantifying the density and volume of cells in a fluid sample. One method of the above is disclosed in U.S. Patent No. 5,017,497 issued to de Grooth et al. Referring to FIG. 1, the '497 Patent discloses a flow cell 2 through which cells from, for example, blood or the like, flow substantially one by one therethrough. A laser input 4 emits a polarized beam of laser light that is oriented substantially orthogonally to the flow of blood cell through flow cell 2 such that the polarized laser light impinges upon the blood cells as they pass through flow cell 2. By "polarized" it is meant that the plane of the electric field oscillization of the laser light is uniform. An optical lens 6 has an aperture which limits the cone of scattered light from the blood cells that can be collected to 72* or less. The central axis of the cone of lens 6 is 90* to both the path of the polarized laser light and the flow of blood cells through flow cell 2. The scattered light eminating from lens 6 is columnated in a matter known in the art. The scattered light now has a mixed polarization that is characteristic of the cell type. The light next passes through a beam splitter 8 that divides the light into two separate beams. A first light beam, substantially concentric with the light beam that originally eminated from lens 6, passes WO 00/49387 PCT/USOO/04069 2 through first polarization analyzer 10. Polarization analyzer 10 is configured to pass therethrough only polarized light having a vector the same as the original laser light. The second beam eminating from beam splitter 8 is oriented substantially perpendicular to the orientation of the first beam eminating from beam splitter 8. This second beam enters second polarization analyzer 12. Second polarization analyzer 12 is configured to pass therethrough only light having a polarization vector substantially orthogonal to the polarization vector of the other beam from beam splitter 8 that passed through first polarization analyzer 10. The beams that pass through first polarization analyzer 10 and second polarization 12 enter polarized detector 14 and depolarized light detector 16, respectively. The ratio of the outputs of polarized light detector 14 and depolarized light detector 16, based on intensity, provide the depolarization ratio. As shown in FIG. 4 eosinophils, a subset of leukocytes (white blood cells), depolarize the right angle of scattered light quantified by the above configuration to a greater degree than other glucosites. FIG. 4 is a graphical representation having the output of polarized light detector 14 as one axis and the output of depolarized light detector 16 as the axis. While the above invention does provide some useful data regarding leukocytes, and more specifically eosinophils, as shown in FIGS. 6B, 7B, 8B and 9B, the cluster points within the eosinophil cluster (the cluster points above the angled threshold line on the graphical representation having "DEPOL" as one axis and "ORTHAGONAL" as the other axis) are quite condensed. The dense nature of the points within the eosinophil cluster results in difficulty for the computer software programs that ascertain and identify clusters to accurately identify eosinophil clusters. Additionally, this prior art configuration requires expensive optical devices such as photo multiplier tubes, and lens 6, first polarization amplifier 10 and second polarization amplifier 12. A need thus exists for a flow cytometer apparatus and related method in which the cell cluster points are less dense for ease of characterization of the different cell clusters. A need also exists for the above apparatus and method which has fewer and less expensive components.
WO 00/49387 PCT/USO0/04069 SUMMARY OF THE INVENTION The high numerical aperture flow cytometer of the present invention includes a flow cell and a laser input. The laser input emits a beam of light that is oriented substantially orthoganilly to the flow of blood cells through the flow cell such that laser light impinges upon the blood cells as they pass through the flow cell. Unlike the prior art, the laser light emitted by the laser input need not be polarized for analysis of the cells according to the present invention. A portion of the beam from the laser input that impinges upon the blood cells in the flow cell is scattered at a substantially right angle to the beam of laser input ("right angle scatter light"). A second portion of the beam from the laser input that impinges upon the cells in the flow cell is scattered at a much lower angle than 900. This scatter is termed "low angle forward scatter light" and has an angle of from about 20 to about 50 from the orientation of the original beam from laser input. A right angle scatter light detector is oriented to receive the previously mentioned right angle scatter light. The right angle scatter light detector is preferably located about 2 millimeters from the blood cells in the flow cell. An important aspect of the present invention is that, at the distance of about 2 millimeters from the blood cells, the right angle scatter light detector collects a cone of scattered light of at least 1000 or greater, and preferably 1300 or greater. It is this larger light cone value over the prior art light cone of about 720 that results in the greater cluster separation in the present invention due to the larger signal gathered. In contrast, the smaller 720 cone of the prior art results in missed signals and lesser cluster separation. A low angle forward scatter light detector is oriented to capture the previously mentioned low angle forward scatter light oriented at about 20 to about 50 from the beam of the laser input. In one embodiment of the present invention, both right angle scatter light detector and low angle forward scatter light detector are employed in order to produce a 2 dimensional cytrogram. However, it should be noted that in another embodiment of the WO 00/49387 PCT/USOO/04069 4 present invention, only right angle scatter light detector is employed, low angle forward scatter light detector is not employed, and characterization of eosinophils is possible. BRIEF DESCRIPTION OF THE DRAWINGS These and other objects and features of the invention will become more fully apparent when the following detailed description of the invention is read in conjunction with the accompanying drawings. FIG. 1 is a schematic representation of the electro-optical components of prior art; FIG. 2 is a schematic representation of the electro-optical components of the present invention; FIG. 3 is a block diagram of the electronic processing components of the present invention; FIG. 4 is a graphical representation of the separation of eosinophils and other white blood cell components based on light scatter in the prior art; FIG. 5 is a graphical representation of the separation of eosinophils and other white blood cell components based on light scatter in the present invention; FIG. 6A is a graphical representation of 2% canine eosinophil data employing the prior art; FIG. 6B is a graphical representation of 2% canine eosinophil data employing the present invention; FIG. 7A is a graphical representation of 8% canine eosinophil data employing the prior art; FIG. 7B is a graphical representation of 8% canine eosinophil data employing the present invention; WO 00/49387 PCT/USOO/04069 5 FIG. 8A is a graphical representation of 10% canine eosinophil data employing the prior art; FIG. 8B is a graphical representation of 10% canine eosinophil data employing the present invention; FIG. 9A is a graphical representation of human eosinophil data employing the prior art; and FIG. 9B is a graphical representation of human eosinophil data employing the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Referring to FIG. 2, the high numerical aperture flow cytometer of the present invention includes a flow cell 18, which is preferably a quartz flow cell manufactured by Opco Laboratories of Fitchburg, Massachusetts. Preferably flow cell 18 has a flow length of about 1 centimeter and a cross section of 4 millimeter by 4 millimeter. Cells from, for example, blood or the like, flow substantially one by one through flow cell 18 during analysis. Laser input 20 emits a beam of light that is oriented substantially orthoganilly to the flow of blood cells through flow cell 18 such that laser light impinges upon the blood cells as they pass through flow cell 18. Unlike the prior art, the laser light emitted by laser input 20 need not be polarized for analysis of the cells according to the present invention. Laser input 20 maybe for example a 635 manometer semiconductor diode laser with an output power of 10 miliwatts, model No. HL6320G manufactured by Hatachi and available from Thor Labs, Inc. of Newton, New Jersey. A portion of the beam from laser input 20 that impinges upon the blood cells in flow cell 18 is scattered at a substantially right angle to the beam of laser input 20 ("right angle scatter light"). A second portion of the beam from laser input 20 that impinges upon the cells in flow cell 18 is scattered at a much lower angle than 90*. This scatter is termed "low angle forward scatter light" and has an angle of from about 20 to about 5* from the orientation of the original beam from laser input 20. Right angle scatter light detector 22 is oriented to receive the previously WO 00/49387 PCT/US0O/04069 6 mentioned right angle scatter light. Right angle scatter light detector is preferably located about 2 millimeters from the blood cells in the flow cell 18. An important aspect of the present invention is that, at the distance of about 2 millimeters from the blood cells, right angle scatter light detector 22 collects a cone of scattered light of at least 100* or greater, and preferably 130* or greater. It is this larger light cone value over the prior art light cone of about 72* that results in the greater cluster separation in the present invention due to the larger signal gathered. In contrast, the smaller 72* cone of the prior art results in missed signals and lesser cluster separation. Low angle forward scatter light detector 24 is oriented to capture the previously mentioned low angled forward scatter light oriented at about 2* to about 50 from the beam of laser input 20. Both right angle scatter light detector 22 and low angle forward scatter light detector 24 can be, for example, silicone PIN photodiodes Model No. S5106PIN manufactured by Hamamatsu Corp. of Bridgewater, New Jersey. In one embodiment of the present invention, both right angle scatter light detector 22 and low angle forward scatter light detector 24 are employed in order to produce a 2 dimensional cytrogram. However, it should be noted that in another embodiment of the present invention, only right angle scatter light detector 22 is employed, low angle forward scatter light detector 24 is not employed, and characterization of eosinophils is possible. While the electro-optical elements of FIG. 2 have been described above using specific components, it will readily be apparent to one skilled in the art that different components can be employed to achieve the desired results described above. More specifically, reference is made to Practical Flow Cytometry 3rd Ed. 1995 by Howard M. Shapiro, Wiley-Liss Publisher, ISBN No. 0-471-30376-3, which is incorporated herein by reference. Referring to FIG. 3, the electrical outputs from right angle scatter light detector 22 and low angle forward scatter light detector 24, which may be in voltage or current form, for example, are amplified by preamplifier 26 and then sent to signal processor 28. Signal processor 28 measures the area under the voltage or current curve, or measures the peak of WO-00/49387 PCT/US00/04069 7 the voltage or current curve, received from right angle light scatter detector 22 and/or low angle forward scatter light detector 24. The data from signal processor 28 is converted by analog to digital converter 30. The digital data is next processed by central processing unit 32 based on software programs to display the data in graphical representation on display 34. It will be readily apparent to those skilled in the art that the signal amplification, processing, conversion and display can be accomplished by many well known methods, including but not limited to those disclosed in Practical Flow Cytometry 3 rd Ed. by Howard M. Shapiro, 1995 Wiley-Liss Publishers, ISBN No. 0-471-30376-3, incorporated herein by reference. Referring to FIG. 5, the output of the data from the flow cytometer of the present invention is shown. FIG. 5 has the output of right angle scatter light detector 22 as one axis and the output of low angle forward scatter light detector 24 as the other axis. Eosinophils are located to the right of the software threshold line and, as shown in FIGS. 6A, 7A, 8A, and 9A, produce cluster points that are less concentrated than are those of the prior art. Computer software programs employed to identify clusters based on cluster points can thus do so more reliably with the present invention. Next referring to FIGS. 6A, 6B, 7A, 7A, 7B, 8A, 8B, 9A and 9B, graphical representations of leukocyte identification is shown, with specific reference to eosinophil identification. The data of FIGS. 6A, 7A, 8A, and 9A was employed using the apparatus of the present invention. In FIGS. 6A, 7A, 8A, and 9A the term R2 denotes primarily lymphocytes, R3 denotes primarily monocytes, R4 denotes primarily neutrophils and R5 denotes primarily eosinophils. FIGS. 6B, 7B, 8B, and 9B pertain to data employing an apparatus substantially disclosed in US Patent No. 5,017,497. Whole blood samples of either canine or human blood were prepared as follows before analyzing with the apparatus of present invention or the prior art. The whole blood sample was diluted 10 to 1 in phosphate buffered saline. Then 40 microliters of the phosphate buffered saline treated whole blood sample was mixed with 1,200 microliters of a lysing solution. The lysing solution consisted of 8.3 grams of ammonium chloride, 1 gram of potassium bicarbonate, 0.37 grams tetrasodium EDTA per liter of lysing solution. The whole blood WO 00/49387 PCT/US00/04069 8 sample was lysed for 20 minutes to one-half of an hour. It will be readily understood by those skilled in the art that lyse time can readily be reduced to between 30 seconds and one minute. A good correlation exists between the eosinophil of the present invention of FIGS. 6A, 7A, 8A and 9A with the eosinophil data of the DEPOL/ORTHOGONAL graphical representation of the prior art as shown in FIGS. 6B, 7B, 8B and 9B. More specifically, regarding FIGS. 6A and 6B, the eosinophil value for the present invention is 2.1% and for the prior art is 2.0%. Regarding FIGS. 7A and 7B, the eosinophil data for the present invention is 7.6% and for the prior art is 8.2%. Regarding FIGS. 8A and 8B the eosinophil data for the present invention is 13.1% and for the prior art is 9.8%. Regarding FIGS. 9A and 9B the eosinophil data for the present invention is 10.8% and for the prior art is 14.6%. For all of the above graphical representations of the present invention, FIGS. 6A, 7A, 8A and 9A an eosinophil cluster is present at R5. Regarding the prior art data of FIGS. 6B, 7B and 8B the SIZE/COMPLEXITY graphical representation shows no eosinophil cluster, while the graphical representation of FIG. 9B does show a cluster. A comparison of the data of the present invention from FIGS. 6A, 7A, 8A and 9A with the prior art data of FIGS. 6B, 7B, 8B and 9B show a marked decreased density or concentration of the cluster points within the eosinophil clusters. The separation of these cluster points allows the software programs that locate and identify different clusters to more readily locate and identify the clusters produced by the apparatus and method of the present invention compared to those of the prior art. While the invention has been described with reference to particular embodiments and applications, it will be appreciated that various embodiments and applications based on the teaching of the present invention are possible.
Claims (28)
1. A high numerical aperture flow cytometer for detecting particles in a fluid sample comprising: a flow cell comprising a passage through which the fluid sample containing the particles to be detected flows; a laser input which emits a beam of light oriented substantially orthogonally to the flow of fluid sample through the flow cell such that the laser light impinges upon the particles in the fluid sample as they pass through the flow cell; and at least one light detector oriented to receive and measure the light after it passes through the flow cell, wherein the light detector collects a cone of scattered light of at least 1000.
2. The flow cytometer of claim 1 wherein the laser light which enters the flow cell is not polarized.
3. The flow cytometer of claim 1 wherein the flow cell is quartz.
4. The flow cytometer of claim 1 wherein the particles are blood cells.
5. The flow cytometer of claim 1 wherein the blood cells are leukocytes.
6. The flow cytometer of claim 1 wherein the leukocytes are eosinophils.
7. The flow cytometer of claim 1 wherein the particles are viruses.
8. The flow cytometer of claim 1 wherein the laser input is a semiconductor diode laser which emits laser light at a wavelength of approximately 635 nm.
9. The flow cytometer of claim I wherein a portion of the beam of light from the laser input which impinges upon the particles as they pass through the flow cell is scattered at a substantially right angle to the beam of laser input.
10. The flow cytometer of claim 1 wherein the cone of scattered light is at least 1300.
11. The flow cytometer of claim 9 wherein the light detector is oriented to receive the beam of light scattered at a substantially right angle to the beam of the laser input.
12. The flow cytometer of claim 9 wherein the light detector is positioned approximately 2 mm from the particles in the flow cell. WO 00/49387 PCTIUS0O/04069 10
13. The flow cytometer of claim 9 wherein another portion of the beam from the laser input which impinges upon the particles as they pass through the flow cell is scattered at an angle of less than 900 from the orientation of the beam from the laser input.
14. The flow cytometer of claim 13 wherein the light scattered at an angle of less than 900 is scattered at an angle of from about 20 to about 5'.
15. The flow cytometer of claim 14 wherein a second light detector is oriented to receive the beam of light scattered at a angle of from 2' to 50 from the orientation of the beam of the laser input.
16. The flow cytometer of claim 15 wherein the light detector and the second light detector are employed to produce a two dimensional cytogram.
17. A method of detecting particles in a fluid sample comprising: providing a high numerical aperture flow cytometer comprising, a flow cell with a passage through which the fluid sample containing the particles to be detected flow; a laser input which emits a beam of light oriented substantially orthogonally to the flow of fluid sample through the flow cell such that the laser light impinges upon the particles in the fluid sample as they pass through the flow cell thereby producing scattered light; and at least one light detector oriented to receive and measure the scattered light after it passes through the flow cell, wherein the light detector collects a cone of scattered light of at least 100'; and passing the fluid sample through the flow cytometer to obtain readings from the light detector(s); constructing a graphical illustration of the readings obtained from the light detector(s); and identifying particles in the sample to be detected. WO 00/49387 PCT/USOO/04069 11
18. The method of claim 17 wherein the light is scattered at a substantially right angle to the beam of laser input, and wherein the light detector is oriented to collect the cone of scattered light.
19. The method of claim 17 wherein the flow cytometer comprises a second light detector oriented to collect light scattered at an angle different from the scattered light collected by the first light detector.
20. The method of claim 19 wherein the first light detector is oriented to receive a beam of light scattered at a substantially right angle to the beam of the laser light, and the second light detector is oriented to receive the beam of light scattered at an angle less than 900 from the beam of the laser light.
21. The method of claim 20 wherein the beam of light scattered at an angle less than 900 from the beam of the laser light is scattered at an angle of from about 20 to about 5* from the beam of the laser light.
22. The method of claim 20 wherein the graphical illustration comprises one axis recording readings from the first light detector and a second axis recording readings from the second light detector.
23. The method of claim 21 wherein the graphical illustration comprises one axis recording readings from the first light detector and a second axis recording readings from the second light detector.
24. The method of claim 17 wherein the particles are leukocytes.
25. The method of claim 24 wherein the leukocytes are eosinophils.
26. The method of claim 18 wherein the particles are eosinophils.
27. The method of claim 17 wherein the light detector collects a cone of scattered light of at least 130".
28. The method of claim 17 wherein the laser light emitted by the laser input is not polarized.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12080499P | 1999-02-19 | 1999-02-19 | |
| US60/120804 | 1999-02-19 | ||
| PCT/US2000/004069 WO2000049387A2 (en) | 1999-02-19 | 2000-02-18 | High numerical aperture flow cytometer and method of using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU3597600A true AU3597600A (en) | 2000-09-04 |
| AU768616B2 AU768616B2 (en) | 2003-12-18 |
| AU768616C AU768616C (en) | 2004-12-16 |
Family
ID=22392650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU35976/00A Ceased AU768616C (en) | 1999-02-19 | 2000-02-18 | High numerical aperture flow cytometer and method of using same |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1095256A2 (en) |
| JP (1) | JP2002537557A (en) |
| AU (1) | AU768616C (en) |
| CA (1) | CA2329031C (en) |
| WO (1) | WO2000049387A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6149867A (en) | 1997-12-31 | 2000-11-21 | Xy, Inc. | Sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
| US6618143B2 (en) | 2000-02-18 | 2003-09-09 | Idexx Laboratories, Inc. | High numerical aperture flow cytometer and method of using same |
| WO2002043486A1 (en) | 2000-11-29 | 2002-06-06 | Xy, Inc. | System for in-vitro fertilization with spermatozoa separated into x-chromosome and y-chromosome bearing populations |
| US7169548B2 (en) | 2002-09-13 | 2007-01-30 | Xy, Inc. | Sperm cell processing and preservation systems |
| DK2305832T3 (en) | 2003-03-28 | 2022-05-23 | Inguran Llc | Method for providing sexed animal semen |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4818103A (en) * | 1981-05-15 | 1989-04-04 | Ratcom | Flow cytometry |
| US4606636A (en) * | 1983-10-25 | 1986-08-19 | Universite De Saint-Etienne | Optical apparatus for identifying the individual multiparametric properties of particles or bodies in a continuous flow |
| NL8601000A (en) * | 1986-04-21 | 1987-11-16 | Jan Greve T H Twente Afdeling | THE USE OF POLARIZED LIGHT IN FLOW CYTOMETRY. |
| US5057413A (en) * | 1988-06-13 | 1991-10-15 | Becton, Dickinson And Company | Method for discriminating between intact and damaged cells in a sample |
| US4954715A (en) * | 1989-06-26 | 1990-09-04 | Zoeld Tibor | Method and apparatus for an optimized multiparameter flow-through particle and cell analyzer |
| US5631165A (en) * | 1994-08-01 | 1997-05-20 | Abbott Laboratories | Method for performing automated hematology and cytometry analysis |
| AU3271895A (en) * | 1994-08-01 | 1996-03-04 | Abbott Laboratories | Method and apparatus for performing automated analysis |
| JP3324050B2 (en) * | 1994-10-31 | 2002-09-17 | 日本光電工業株式会社 | Leukocyte classification reagent and leukocyte classification method |
| US5650847A (en) * | 1995-06-14 | 1997-07-22 | Erkki Soini | Method and device for determination of parameters of individual microparticles |
| JP3504029B2 (en) * | 1995-07-04 | 2004-03-08 | シスメックス株式会社 | Particle analyzer |
| EP0805441B1 (en) * | 1996-05-03 | 2003-10-08 | Ciba SC Holding AG | High capacity optical recording medium containing xanthene dyes |
| DE19700648A1 (en) * | 1997-01-10 | 1998-07-23 | Basf Ag | Method and device for determining the size distribution of different types of particles in a sample |
| JP3642658B2 (en) * | 1997-06-30 | 2005-04-27 | シスメックス株式会社 | Urine component analyzer and analysis method |
-
2000
- 2000-02-18 EP EP00914609A patent/EP1095256A2/en not_active Ceased
- 2000-02-18 JP JP2000600079A patent/JP2002537557A/en active Pending
- 2000-02-18 AU AU35976/00A patent/AU768616C/en not_active Ceased
- 2000-02-18 WO PCT/US2000/004069 patent/WO2000049387A2/en not_active Application Discontinuation
- 2000-02-18 CA CA002329031A patent/CA2329031C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1095256A2 (en) | 2001-05-02 |
| AU768616B2 (en) | 2003-12-18 |
| JP2002537557A (en) | 2002-11-05 |
| CA2329031A1 (en) | 2000-08-24 |
| WO2000049387A9 (en) | 2001-09-27 |
| CA2329031C (en) | 2003-09-23 |
| WO2000049387A3 (en) | 2001-02-15 |
| AU768616C (en) | 2004-12-16 |
| WO2000049387A2 (en) | 2000-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002327820B2 (en) | High numerical aperture flow cytometer and method of using same | |
| AU2002327820A1 (en) | High numerical aperture flow cytometer and method of using same | |
| US6320656B1 (en) | High numerical aperture flow cytometer and method of using same | |
| US7390662B2 (en) | Method and apparatus for performing platelet measurement | |
| US5125737A (en) | Multi-part differential analyzing apparatus utilizing light scatter techniques | |
| EP0698211B1 (en) | Reticulocyte analyzing method and apparatus utilizing light scatter techniques | |
| JP3375203B2 (en) | Cell analyzer | |
| EP0442025B1 (en) | Optical particle analyzing apparatus having two types of light sources | |
| JP2815435B2 (en) | Particle analyzer and blood cell counter | |
| JPH05322885A (en) | Instrument for analyzing cell in urine | |
| JPH05322883A (en) | Instrument for analyzing cell in urine | |
| AU768616C (en) | High numerical aperture flow cytometer and method of using same | |
| WO2020147255A1 (en) | Sample optical detection device, sample detection method, and sample analyzer | |
| US5684584A (en) | Apparatus for analyzing cells in urine | |
| US5735274A (en) | Apparatus and method for analyzing particles including shifting a judgement region | |
| Gray et al. | A new method for cell volume measurement based on volume exclusion of a fluorescent dye | |
| JPH0921740A (en) | Method and apparatus for determining particle judging criterion and particle analyzer employing it | |
| JPS6193932A (en) | Particle analysis instrument |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20040429 |